Preclinical efficacy and safety studies designed for better drug-development decisions
IPS Therapeutique helps sponsors design, execute, interpret, and position preclinical studies within integrated testing strategies. Our flexible, collaborative approach combines scientific rigor, clear communication, and practical development insight to move programs forward efficiently.
More than model execution
A strong preclinical study is not only about running a model. It is about asking the right questions, selecting the right endpoints, executing the study rigorously, and interpreting the results in the context of the therapeutic program.
Design
Mechanism-driven model selection, treatment timing, route of administration, controls, and endpoint strategy.
Execute
Rodent, rabbit, and pig studies conducted with scientific rigor, practical flexibility, and clear communication.
Interpret
Integrated analysis of functional, biochemical, histological, and translational data.
Advance
Cost-conscious recommendations to help sponsors make the next development decision.
Preclinical models across major therapeutic areas
Disease-relevant models with study designs adapted to the compound, mechanism of action, route of administration, and development stage.